Z3 Capital Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Z3 Capital Partners's BMY Position: Q2 2026 in Review
Z3 Capital Partners reduced its Bristol-Myers Squibb (BMY) stake by 2.5% in Q2 2026, selling an estimated $7.18K and leaving 4,780 shares worth $275K. The position accounts for 0.06% of the portfolio, ranked #158.
Z3 Capital Partners first reported a position in BMY in Q4 2025 and has held it in 3 quarters since. The position peaked at $297K in Q1 2026. 2,401 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Z3 Capital Partners held 4,780 shares of Bristol-Myers Squibb worth $275K as of Q2 2026.
- Z3 Capital Partners sold 125 Bristol-Myers Squibb shares in Q2 2026, an estimated $7.18K.
- Bristol-Myers Squibb made up 0.06% of Z3 Capital Partners's portfolio in Q2 2026, its #158 holding.
- Z3 Capital Partners first reported a position in Bristol-Myers Squibb in Q4 2025 and has held it in 3 quarters since.
- Z3 Capital Partners's Bristol-Myers Squibb position peaked at $297K in Q1 2026.
- 2,401 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Z3 Capital Partners's 13F filing for Q2 2026, filed 28 Jul 2026.